Vehreschild MJGT, Ducher A, Louie T, Cornely OA, et al. An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones. J Antimicrob Chemother 2022;77:1155-1165.
PMID: 35016205